Disseminated Mycobacterium celatum disease with prolonged pulmonary involvement

Int J Infect Dis. 2014 Sep:26:88-90. doi: 10.1016/j.ijid.2014.02.020. Epub 2014 Jul 5.

Abstract

Mycobacterium celatum is a rare cause of human infection, causing disseminated disease in immunosuppressed individuals. Infections localized to the lungs and the lymph nodes have also been reported in immunocompetent individuals. The existing literature on the subject is limited as are experiences with treatment regimens and durations. In the case presented herein, two different treatment regimens were applied to an immunocompromised HIV-negative patient with primary skin involvement and extensive pulmonary involvement due to suspected relapse on isoniazid, ethambutol, and clarithromycin treatment. The treatment regimen was changed to azithromycin, ciprofloxacin, and pyrazinamide and the treatment duration was prolonged to a total of 24 months, with good effect.

Keywords: Mycobacterium celatum; Non-tuberculous Mycobacterium.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anti-Bacterial Agents / therapeutic use
  • Azithromycin / therapeutic use
  • Ciprofloxacin / therapeutic use
  • Clarithromycin / therapeutic use
  • Drug Therapy, Combination
  • Ethambutol / therapeutic use
  • Female
  • Humans
  • Isoniazid / therapeutic use
  • Lung / diagnostic imaging
  • Lung / pathology
  • Lung Diseases / diagnosis
  • Lung Diseases / drug therapy
  • Lung Diseases / microbiology
  • Mycobacterium / drug effects
  • Mycobacterium Infections / diagnosis
  • Mycobacterium Infections / drug therapy*
  • Mycobacterium Infections / microbiology
  • Pyrazinamide / therapeutic use
  • Radiography

Substances

  • Anti-Bacterial Agents
  • Pyrazinamide
  • Ciprofloxacin
  • Azithromycin
  • Ethambutol
  • Clarithromycin
  • Isoniazid